PyInvesting

Market research

NANO.PA Nanobiotix S.A

Current ticker: NANO.PA

PA EUR Healthcare

Latest close

24.34 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
1B
P/E ratio
Not available
Analyst target
52.202
Dividend yield
Not available
Beta
0.54

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Nanobiotix S.A is currently in a long term downtrend where the price is trading 2.2% below its 200 day moving average.

From a valuation standpoint, the stock is 1518.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 4423.3.

Nanobiotix S.A's total revenue sank by 89.7% to $37K since the same quarter in the previous year.

Its net income has dropped by 52.5% to $-21M since the same quarter in the previous year.

Finally, its free cash flow grew by 35.1% to $-6M since the same quarter in the previous year.

Based on the above factors, Nanobiotix S.A gets an overall score of 1/5.